Delivery Order SPE2DE24D0013-SPE2D626F769V
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $4,080 on December 9, 2025, with a completion date of December 16, 2025. Designated as contract XPCOV2/FLU/RSV-10, this order procures diagnostic testing supplies and reagents, with performance to be completed at Cepheid's facility in Sunnyvale, California. The contract utilizes no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of...
- The Defense Logistics Agency Medical Supply Chain awarded a $14,960 firm fixed-price delivery order to Cepheid Inc. on November 20, 2025, with an ultimate completion date of December 5, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, represents a relatively modest procurement within Cepheid's broader federal contracting portfolio and likely involves molecular diagnostic reagents or test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a delivery order valued at $5,440 on December 1, 2025, from the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $3,740 on October 26, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation. This delivery order represents a continuation of Cepheid's extensive federal...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 10, 2025, with an ultimate completion date of November 18, 2025. This delivery order, issued under contract number 4569971788 for the XPCOV2/FLU/RSV-10 product line, represents a procurement of molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. The contract carries no set-aside designation and is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on December 5, 2025, for respiratory pathogen diagnostic testing supplies. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with an ultimate completion date of December 19, 2025, and carries no set-aside designation. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of molecular diagnostic systems and...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F769VDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,632.00 to Cepheid Inc. on December 4, 2025, for the supply of XPCOV2/FLU/RSV-10 diagnostic cartridges. The contract, which is a firm fixed-price delivery order with no set-aside designation, will be completed by December 11, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a routine procurement action for molecular diagnostic testing supplies from the agency's established vendor relationship with Cepheid, the primary federal supplier of GeneXpert diagnostic platform reagents and test kits across multiple Department of Defense and federal healthcare agencies. Cepheid has established itself as a cornerstone supplier of infectious disease diagnostic solutions to federal agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company holds substantial indefinite delivery contracts with the VA, including a $32.8 million IDC with VISN 6 and a $6.7 million IDC with VISN 17, both extending through 2029–2030, which serve as the contracting vehicles for ongoing procurement of molecular diagnostic testing reagents and assays. The current delivery order for respiratory pathogen detection cartridges (COVID-19, influenza, and RSV) reflects routine demand-driven ordering under the Defense Logistics Agency's Medical Supply Chain operations to support federal diagnostic testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 12/3/25 |